| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
59,940,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0 - $0 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile MoonLake Immunotherapeutics is a newly blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Holms Allan G. |
President |
• • • |
2016-12-10 |
5 |
B |
$1,088,000.00 |
$2,147,483,647 |
I/I |
13,117,500 |
26,590,000 |
|
- |
|
| Holms Allan G. |
President |
• • • |
2016-08-01 |
5 |
B |
$10,000.00 |
$2,147,483,647 |
I/I |
13,117,500 |
26,590,000 |
|
- |
|
| Anderson Dan |
CFO |
• • – |
2015-11-23 |
4 |
D |
$0.00 |
$0 |
D/D |
(0) |
0 |
|
- |
|
| Holms Val M. |
CEO and President |
• • • |
2011-12-27 |
4 |
A |
$0.00 |
$0 |
D/D |
6,235,000 |
26,350,000 |
|
- |
|
| Boleneus David E. |
Director |
– • – |
2011-02-04 |
4 |
B |
$0.25 |
$10,000 |
D/D |
40,000 |
290,000 |
2.39 |
- |
|
| Armstrong Steven D. |
Director |
– • – |
2011-01-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
250,000 |
|
- |
|
| Herman Landeis |
Director |
– • – |
2011-01-04 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
250,000 |
|
- |
|
| Holms Val M. |
PRESIDENT, CEOOfficer |
• • • |
2010-12-02 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
20,000,000 |
|
- |
|
| Midtlyng Karen |
SECRETARYOfficer |
• • – |
2010-12-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,250,000 |
|
- |
|
| Boleneus David E. |
Director |
– • – |
2010-12-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
250,000 |
|
- |
|
| Blair Frank |
Director |
– • – |
2010-12-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
250,000 |
|
- |
|
| Wetzel Christopher |
Vice PresidentOfficer |
• • – |
2009-03-06 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
125,000 |
|
- |
|
| Kuh Raymond |
Secretary, Treasurer, CFOOffic |
• • – |
2009-02-26 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
125,000 |
|
- |
|
| Edington Janelle |
President, CEOOfficer |
• • • |
2009-02-26 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
500,000 |
|
- |
|
14 Records found
|
1
|
Page 1 of 1 |
|
|
